|Age:||12 - 17|
|Keywords:||Eczema, Atopic dermatitis|
|Type:||Phase 2, Drug Study|
Your participation in this study will last about 7 months with 8 study visits to the study center.
While in this study, in addition to the study medication, you will begin using (or continue to use) topical treatments for atopic dermatitis. The study doctor will tell you how to use these treatments during the study.
Other eligibility criteria will be determined during the initial clinic visit.
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.